These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12970722)

  • 1. Models of metastatic prostate cancer: a transgenic perspective.
    Winter SF; Cooper AB; Greenberg NM
    Prostate Cancer Prostatic Dis; 2003; 6(3):204-11. PubMed ID: 12970722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autochthonous mouse models for prostate cancer: past, present and future.
    Huss WJ; Maddison LA; Greenberg NM
    Semin Cancer Biol; 2001 Jun; 11(3):245-60. PubMed ID: 11407949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
    Kasper S; Smith JA
    J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.
    Duan W; Gabril MY; Moussa M; Chan FL; Sakai H; Fong G; Xuan JW
    Oncogene; 2005 Feb; 24(9):1510-24. PubMed ID: 15674347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies.
    Gabril MY; Duan W; Wu G; Moussa M; Izawa JI; Panchal CJ; Sakai H; Xuan JW
    Mol Ther; 2005 Mar; 11(3):348-62. PubMed ID: 15727931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of pulmonary metastasis.
    Krishnan K; Khanna C; Helman LJ
    Thorac Surg Clin; 2006 May; 16(2):115-24. PubMed ID: 16805200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line.
    Masumori N; Tsuchiya K; Tu WH; Lee C; Kasper S; Tsukamoto T; Shappell SB; Matusik RJ
    J Urol; 2004 Jan; 171(1):439-42. PubMed ID: 14665950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo models of prostate cancer metastasis to bone.
    Singh AS; Figg WD
    J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
    Morgenbesser SD; McLaren RP; Richards B; Zhang M; Akmaev VR; Winter SF; Mineva ND; Kaplan-Lefko PJ; Foster BA; Cook BP; Dufault MR; Cao X; Wang CJ; Teicher BA; Klinger KW; Greenberg NM; Madden SL
    Prostate; 2007 Jan; 67(1):83-106. PubMed ID: 17013881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
    Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
    Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling prostate cancer: a perspective on transgenic mouse models.
    Jeet V; Russell PJ; Khatri A
    Cancer Metastasis Rev; 2010 Mar; 29(1):123-42. PubMed ID: 20143131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of prostate cancer.
    Sharma P; Schreiber-Agus N
    Oncogene; 1999 Sep; 18(38):5349-55. PubMed ID: 10498888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling human prostate cancer in genetically engineered mice.
    Wang F
    Prog Mol Biol Transl Sci; 2011; 100():1-49. PubMed ID: 21377623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.